BOSCUTTI, GIULIA
 Distribuzione geografica
Continente #
NA - Nord America 1.164
AS - Asia 212
EU - Europa 168
OC - Oceania 12
AF - Africa 5
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.564
Nazione #
US - Stati Uniti d'America 1.163
CN - Cina 120
SG - Singapore 77
IT - Italia 39
FI - Finlandia 34
GB - Regno Unito 23
DE - Germania 19
SE - Svezia 18
FR - Francia 13
AU - Australia 12
UA - Ucraina 8
EG - Egitto 5
IN - India 5
NL - Olanda 5
JP - Giappone 4
ID - Indonesia 3
IE - Irlanda 3
A2 - ???statistics.table.value.countryCode.A2??? 1
BO - Bolivia 1
BR - Brasile 1
CH - Svizzera 1
ES - Italia 1
GR - Grecia 1
HK - Hong Kong 1
MD - Moldavia 1
NO - Norvegia 1
PA - Panama 1
PK - Pakistan 1
PL - Polonia 1
TR - Turchia 1
Totale 1.564
Città #
Woodbridge 176
Ann Arbor 170
Fairfield 127
Houston 64
Singapore 63
Chandler 61
Wilmington 59
Ashburn 57
Seattle 57
Cambridge 46
Jacksonville 36
Santa Clara 36
Boardman 35
Beijing 25
Nanjing 22
Medford 21
Princeton 21
Des Moines 15
Guangzhou 12
Helsinki 12
San Diego 12
Melbourne 11
Roxbury 8
Cagliari 7
Jinan 7
New York 7
Hefei 6
Padova 6
Norwalk 5
Norwich 5
Changsha 4
Derby 4
Hebei 4
Kunming 4
London 4
Nanchang 4
Dublin 3
Indiana 3
Ogden 3
Al Maḩallah al Kubrá 2
Bandung 2
Catania 2
Itri 2
Jiaxing 2
Kilburn 2
Livorno 2
Milan 2
Raleigh 2
Shanghai 2
Shenyang 2
Tianjin 2
Wuhan 2
Alexandria 1
Baotou 1
Bengaluru 1
Borås 1
Chisinau 1
Chongqing 1
Dearborn 1
Florence 1
Fuzhou 1
Hong Kong 1
Hounslow 1
Islington 1
Jakarta 1
Jian 1
Kumamoto 1
La Paz 1
Landshut 1
Lappeenranta 1
Logan 1
Los Angeles 1
Lviv 1
Lüleburgaz 1
Multan 1
Osaka 1
Pavia 1
Porto Alegre 1
Porto Torres 1
Prescot 1
Redwood City 1
Rockville 1
San Francisco 1
San Jose 1
Taiyuan 1
Tappahannock 1
Telde 1
Tokyo 1
Utrecht 1
Vancouver 1
Warsaw 1
Xian 1
Zhengzhou 1
Zurich 1
Totale 1.290
Nome #
Rational design of gold(III)-dithiocarbamato peptidomimetics for the targeted anticancerchemotherapy 127
Ruthenium(II/III)-based Compounds with Encouraging Antiproliferative Activity against Non-Small Cell Lung Cancer 123
Cell and cell-free mechanistic studies on two gold(III) complexes with proved antitumor properties 120
t-Butylsarcosinedithiocarbamato gold(III)-based anticancer agents: design, in vitro biological evaluation and interaction with model biomolecules 97
Gold-based anticancer derivatives of oligopeptides: synthesis, characterization, delivery strategies and biological activity 93
Anticancer Gold(III) Peptidomimetics: From Synthesis to in vitro and ex vivo Biological Evaluations 92
Insights into the Reactivity of Gold-Dithiocarbamato Anticancer Agents toward Model Biomolecules by Using Multinuclear NMR Spectroscopy 79
Gold-based peptidomimetics for a targeted anticancer therapy 78
Beyond Platinums: Gold Complexes as Anticancer Agents 70
CCK8 peptide-labeled Pluronic® F127 micelles as a targeted vehicle of gold-based anticancer chemotherapeutics 70
Perspective gold(III)-dithiocarbamato anticancer therapeutics: learning from the past, moving to the future. 69
Ruthenium(II/III) Complexes of S-donor Ligands: Synthesis, Characterisation and in vitro Cytotoxicity Activity toward Lung Cancer Cells 52
Copper(II)- and Ruthenium(III)-based complexes with promising anticancer activity 52
null 50
Ubiquitin-Proteasome System impairment by the Gold(III) complex derivative AuL12 48
CCK8 receptor-mediated cancer treatment strategies in target therapy 48
Synthesis and characterization of ruthenium(II/III) complexes with S-donor ligands: in vitro cytotoxic activity toward lung cancer cells 46
Promising Anticancer Mono- and Dinuclear Ru(III) and Ru(II) Dithiocarbamato Complexes 46
Selective delivery of chemotherapeutics into tumor cells by use of targeting peptides 42
Insights into the reactivity of gold(III)-dithiocarbamato anticancer agents toward model biomolecules from multinuclear NMR spectroscopy 39
From cisplatin to world-shattering gold(III) anticancer agents 39
null 37
Chiral gold(III)-dithiocarbamato peptidomimetics for the anticancer chemotherapy 30
Biological studies on Au(III) peptidomimetics about to enter Phase I clinical trials 30
Synthetic biomimetic hydroxyapatite nanocrystals for anticancer drug delivery 12
Totale 1.589
Categoria #
all - tutte 5.837
article - articoli 3.030
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 280
Totale 9.147


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020160 0 0 0 0 0 12 39 38 16 17 25 13
2020/2021171 6 9 0 13 6 18 1 15 22 42 30 9
2021/2022236 12 35 30 8 18 11 7 21 13 2 16 63
2022/2023185 40 1 2 11 39 27 1 18 31 0 12 3
2023/2024119 6 14 12 8 9 8 4 8 5 11 18 16
2024/2025198 13 45 32 21 69 18 0 0 0 0 0 0
Totale 1.589